HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.

Abstract
Telbivudine, beta-L-2'-deoxythymidine (LdT), is a new beta-L-nucleoside analogue with potent inhibitory activity against the hepatitis B virus. In in vitro studies and animal models, telbivudine has demonstrated potent and specific antiviral activity against hepatitis B. Additionally, in preclinical animal toxicology studies, telbivudine showed no adverse side effects or adverse effects on mitochondrial function. The promising results of the early in vitro and animal telbivudine studies prompted the development and initiation of Phase I and II human clinical trials. The Phase I clinical study demonstrated that end-of-treatment virological response rates were better for telbivudine recipients at multiple dosing levels as compared with placebo patients. The subsequent Phase IIb human clinical study demonstrated superior antiviral efficacy of telbivudine, significantly better ALT normalisation and better hepatitis B e-antigen loss as compared with lamivudine. Telbivudine was well tolerated with no identified safety issues. Virological breakthrough with telbivudine was significantly lower than with lamivudine.
AuthorsSteven-Huy B Han
JournalExpert opinion on investigational drugs (Expert Opin Investig Drugs) Vol. 14 Issue 4 Pg. 511-9 (Apr 2005) ISSN: 1744-7658 [Electronic] England
PMID15882124 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Nucleosides
  • Pyrimidinones
  • Reverse Transcriptase Inhibitors
  • Telbivudine
  • Lamivudine
  • Thymidine
Topics
  • Animals
  • Antiviral Agents (administration & dosage, pharmacology, therapeutic use)
  • Disease Models, Animal
  • Hepatitis B, Chronic (drug therapy)
  • Humans
  • Lamivudine (therapeutic use)
  • Nucleosides (administration & dosage, pharmacology, therapeutic use)
  • Pyrimidinones (administration & dosage, pharmacology, therapeutic use)
  • Randomized Controlled Trials as Topic
  • Reverse Transcriptase Inhibitors (therapeutic use)
  • Telbivudine
  • Thymidine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: